Rx Medicare

Patients suffering from acute pain and healthcare professionals who treat pain have a new treatment option: NUCYNTA(TM) (tapentadol) CII immediate release tablets. This new medication for the relief of moderate to severe acute pain in patients 18 years of age or older is now available by prescription only in 50-mg, 75-mg and 100-mg tablets, announced PriCara,(R) Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Read More…

Related Posts

• Tapentadol Tablets For Moderate To Scute Pain In Over 18s Now Available For Use In The United States
• QRxPharma Initiates Pivotal Phase 3 Study Of MoxDuo(TM)IR For Moderate To Severe Acute Pain
• ROXRO Announces FDA Accepts For Review NDA For ROX-888 For The Management Of Acute Moderate To Severe Pain
• FDA Approves Morphine Sulfate Oral Solution For Relief Of Acute And Chronic Pain
• New Drug Application Submitted To FDA For Tapentadol Extended Release Tablets For Management Of Chronic Pain
• Nutra Pharma Announces Online Availability Of Cobroxin For The Treatment Of Moderate To Severe Chronic Pain
• 95% Of Patients In Pain Are Still In Moderate To Severe Chronic Pain Despite One Year Of Treatment
• XenaCare Holdings Announces National Print Advertising Campaign For Cobroxin, A Treatment For Moderate To Severe (Stage 2) Pain
• China Aoxing Pharmaceutical Company Announces Submission Of NDA Of Its Leading Narcotic Drug For The Treatment Of Acute Moderate To Severe Cough
• Nutra Pharma Announces Launch Of Cobroxin, An Over-the-Counter (OTC) Treatment For Stage 2 (Moderate To Severe) Chronic Pain
• FDA Approves EMBEDA(TM) For Management Of Moderate To Severe Chronic Pain
• New Phase 3 Study Of Tapentadol Immediate Release Tablets Published In Current Medical Research And Opinion Journal
• Three Clinical Presentations On Tapentadol Extended Release Tablets For Chronic Pain Featured At 2009 American Pain Society Annual Meeting
• Repros Thera. Announces That Proellex Significantly Reduced Pain In A U.S. Phase 2 Clinical Trial In Women With Moderate To Severe Endometriosis
• Acute Study Demonstrates Safety Of Vertos Medical’s Mild(R) Procedure; Findings Appear In Pain Physician Journal

Tags: acute, available, immediate, moderate, nucyntatm, pain, relief, severe, tablets, tapentadol

This entry was posted on Monday, June 29th, 2009 at 8:06 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.